Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 329

1.

Management of nonvalvular atrial fibrillation: a comprehensive approach.

Iuliano L, Di Matteo A, Straface G.

Indian J Med Sci. 2009 Sep;63(9):419-30. doi: 10.4103/0019-5359.56111. Review.

PMID:
19805924
2.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.

PMID:
21329865
3.

[Atrial fibrillation and thromboembolic events prevention. State of the art].

Matteoli S, Trappolini M, Chillotti FM.

Minerva Cardioangiol. 2001 Feb;49(1):1-13. Review. Italian.

PMID:
11279381
4.

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

[No authors listed]

Arch Intern Med. 1994 Jul 11;154(13):1449-57. Erratum in: Arch Intern Med 1994 Oct 10;154(19):2254.

PMID:
8018000
5.

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M; AFFIRM Investigators.

Am Heart J. 2005 Apr;149(4):650-6.

PMID:
15990748
6.

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.

7.

What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?

Lip GY.

J R Coll Physicians Edinb. 2012;42 Suppl 18:35-44. doi: 10.4997/JRCPE.2012.S04.

PMID:
22518392
8.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
9.

Antithrombotic treatment in atrial fibrillation.

Lip GY, Boos CJ.

Postgrad Med J. 2008 May;84(991):252-8. doi: 10.1136/hrt.2005.066944. Review.

PMID:
18508982
10.

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Själander A, Wallentin L, Rosenqvist M, Svensson P.

Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Swedish. No abstract available.

PMID:
19006862
11.

Antithrombotic therapies for stroke prevention in atrial fibrillation.

Economides Muñoz C, Singh BN.

Minerva Cardioangiol. 2004 Apr;52(2):125-39. Review.

12.

[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].

Prisco D.

Haematologica. 2001 Sep;86(9 Suppl):12-3. Italian. No abstract available.

PMID:
11759618
13.

Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH.

Arch Intern Med. 1996 Nov 11;156(20):2311-6.

PMID:
8911237
14.

Stroke prevention in elderly patients with atrial fibrillation.

Lew SJ, Lim JK.

Singapore Med J. 2002 Apr;43(4):198-201.

PMID:
12188065
15.

The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.

Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN.

J Cardiovasc Electrophysiol. 2010 May;21(5):501-7. doi: 10.1111/j.1540-8167.2009.01661.x. Epub 2009 Dec 15.

PMID:
20021521
16.

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.

Hughes M, Lip GY; Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence.

Thromb Haemost. 2008 Feb;99(2):295-304. doi: 10.1160/TH07-08-0508. Review.

PMID:
18278178
17.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
18.

The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable.

Evans A, Davis S, Kilpatrick C, Gerraty R, Campbell Do, Greenberg P.

J Clin Neurosci. 2002 May;9(3):268-72.

PMID:
12093132
19.

[Anticoagulation therapy in paroxysmal atrial fibrillation].

Risøe C, Gjesdal K.

Tidsskr Nor Laegeforen. 2004 Apr 1;124(7):950-2. Review. Norwegian.

20.

Supplemental Content

Support Center